LPTX icon

Leap Therapeutics
LPTX

Overview Fund Activity

44 hedge funds and large institutions have $22.5M invested in Leap Therapeutics in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
+1
Holders Change %
+2.33%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
11
Reduced
10
Closed
9
Calls
$29K
Puts
$24K
Net Calls
+$5K
Net Calls Change
+$100K

Top Buyers

1
Balyasny Asset Management
Balyasny Asset Management
Illinois
$1.78M
2
Vanguard Group
Vanguard Group
Pennsylvania
$2.31M
3
SAM
Simplify Asset Management
Nevada
$1M
4
BC
BIT Capital
Germany
$878K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
$750K

Top Sellers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
$1.28M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$0
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$78.4K
4
PA
Perceptive Advisors
New York
$0
5
BlackRock
BlackRock
New York
$77.9K
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of America
51
Bank of America
North Carolina
– -$2.2K -531 Closed
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
– -$2K -373 Closed
QT
53
Quantbot Technologies
New York
– -$207 -50 Closed
1 2
3